Nonetheless, the improvements in depressive symptoms after long-term non-pharmacological, behavioral-cognitive therapy for T1DM and T2DM with comorbid depression and distress were not associated with increased adiponectin levels in the 12-month follow-up [60]. This evidence concerns the gene ADIPOQ and depressive symptom measurement.